The pituitary response to a continuous i.v. LH-RH administration (15 pg/h/3 h) associated with physiological or pharmacological doses of several steroid hormones such as estradiol (E,), progesterone, 17aOH-progesterone, 20ctOH-progesterone. chlormadinone acetate, testosterone (T) and Sa-dihydrotestosterone (5ctDHT) was evaluated by radioimmunoassayable plasma LH and FSH measurements, in normal and post-menopausal women, normal men, and in a Flinefelter's syndrome subject. Analysis of results indicated that Ez in doses of 132pg/h/6 hs blocks the pituitary response to LH-RH in all cases except in the Klinefelter's syndrome patient. Nevertheless, E, in doses of 66 pg/h/6 hs did not cause a significant inhibitory effect. The infusion of physiological (330 /(g/h/6 hs) or pharmacologj~al (3300-6600 @g/h/6 hs) doses of any of the selected progestational steroids did not block the pituitary response to LH-RH. When chlormad~none acetate was infused together with Ez in normal and postmenopausal women, the inhibitory effect of EZ on the pituitary response to LH-RH was antagonized.
INTRODUCTION
Numerous studies in laboratory animals and man indicate that sex steroids play an important roIe on the feedback regulation of the synthesis and release of pituitary gonadotropins, either by a direct effect on the pituitary gland or through its action on the hypothalamus.
The identification of porcine LH-RH by Matsuo et al. 1971 [1 J permitted the synthesis of a decapeptide with physicochemical and biological properties identical to natural LH-RH [2-51, including the ability to release both LH and FSH from the pituitary gland C&-7] . Availability of the synthetic decapeptide has permitted several clinical investigators to test iu the human the pituitary response to LH-RH administration under selected experiment& conditions and particularly after administration of different sex steroids.
Although most of the recent publications have contributed to our knowledge on the mechanisms in-1 in the control of gonadotropin secretion, there *v contradictory results, and numerous Tents remain to be elucidated. L , should be sent to: Dr.
*. .a1 de la Nutrition. Viaduct0 exico 22, D.F. . Fellow. Training Program in tituto National de la Nutrition .I.
In this communication, our more recent studies conducted to evaluate hormonal responses to constant in~avenous infusions of LH-RH associated with either physiological or pharmacological doses of selected natural or synthetic sex steroids in normal and post-menopausal women, normal men and a Klinefelter's syndrome patient will be presented.
EXPERIMENTAL
Synthetic LH-RH was provided by Farwerke Hoechst, A. C., Frankfurt, Germany. in sterile ampoules each containing 25ng of lyophil~ed decapeptide. The selected steroids were recrystallized several times prior to use and shown to be highly pure by appropriate paper chromatography. A total of 62 tests were performed in 4 post-menopausal women, 4 normal women in different phases of the menstrual cycle, 2 normal men, and in one subject with Klinefelter's syndrome (XXY). The weighed steroids were infused intravenously in all subjects for a 3 or 6 h period as a 0.2 to @5% ethanolic solution in 1OOOml of isotonic saline. The steroids were infused at a rate of 6.6 and 132pg/h for estradiol; 330 and 3300 pg/h for either progesterone, 17clOH-progesterone, 2~OH-progesterone or chlormadinone acetate; 60, 600 and 12~~~h for testosterone; and 6 and 60 s/b for Set-dihydrostestosterone. Studies were initiated between 8a.m. and 9a.m. and the solution c. GUAL c't Ul. administered at a rate of 166 ml/h through an indwelling i.v. catheter with the subjects in sitting position.
LH-RH was infused alone in control tests or associated with the selected steroid for the last 3 h of infusion at a rate of 15 pgg/h.
In the 4 normal menstruating women, the infusion tests were performed either in the early proliferative phase of the cycle (day 6), in the midcycle (days 12-14) or at the mid-luteal phase (day 22). In the post-menopausal women, normal men and in the Klinefelter's Syndrome patient, the infusions were done 7-15 days apart.
In all cases the pituitary response was evaluated by serum LH and FSH measurements in blood samples withdrawn from the catheter at time 0 and at 1-9, and 24 h after the initiation of the infusion. After centrifugation, the serum was separated and kept frozen at -20°C until assayed. Serum LH and FSH levels were determined by double antibody radioimmunoassay according to previously described methodology [S, 9, lo].
RESULTS

Postmenopausal women
As illustrated in Fig.  1 , a 3 h LH-RH administration at a rate of 15 PgLglh in 4 post-menopausal women caused a significant LH increase, with a peak rise after 2 or 3 h of infusion. When in one of these women LH-RH was administered along with a constant estradiol infusion at a rate of 6.6pg/h for 6 consecutive hours, which is comparable to the normal blood production rate of estradiol during the menstrual cycle of the normal women, a peak rise similar to that of the control test in the same patient was obtained. On the contrary, when estradiol was infused at a rate of 132pg/h. which is about IO-20 times above the normal blood production rate in the normal menstruating women, the pituitary LH response was completely blunted.
Progesterone, 17aOH-progesterone and 20rOH-progesterone infused in doses similar to the normal blood prdduction rate seen during the luteal phases of the menstrual cycle or in doses 10 times higher did not inhibit the pituitary LH response to the prolonged LH-RH administration.
Similar results were obtained when chlormadinone acetate was infused in doses of 330 &h/6 consecutive hours.
When chlormadinone acetate was administered as a mixture with pharmacological doses of estradiol. a normal or even enhanced LH response was induced by the 3 h LH-RH infusion.
As shown in Fig. 2 .G.
and .5cc-dihydrotestosterone infusions in doses of 60 madinone acetate on the LH response to a 3 h LHor 600 pg/h and 6 or 604 pg/h respectively, for 6 con-RH administration in different phases of the mensecutive hours.
strual cycle of young normal women. When estradiol Verdi women was infused on day 6 of the menstrual cycle at a rate of 6.6~~h, the pitui~ry LH responses to LH-RH Figure 5 shows the effects of prolonged intravenous were similar to those observed in the early follicular infusions of various regimens of estradiol and chlorphase of control LH-RH tests [l I]; when infused in doses ranging 10-20 times above the normal blood production rate of normal menstruating women (132 pg/h), the LH response was completely blunted in a fashion similar to that observed above in the post-menopausal women. When chlormadinone acetate was infused on day 22 of the menstrual cycle at a rate of 330&h, it did not inhibit the pituitary LH response to LH-RH but induced an antagonistic action of the blocking effect of pharmacological doses of estradiol on the pituitary response to LH-RH stimulation (see right side of Fig. 5 ).
The FSH responses were similar but of lesser magnitude than those already observed for LH (Fig. 6 ).
Normal men steroid hormones shown in Figure 8 , induced smaller steroids in one Klinefelter's syndrome patient. On the FSH responses than those observed in the control control test the peak rise for LH was observed at tests with LH-RH injected alone.
120 min of infusion with a delta value of 110 mIU/ml.
Klinefelter's syndrome FSH increase was seen at 180min with a secondary rise for the following 3 h to give a final delta value Figure 9 shows the LH and FSH pituitary response of 63 mIU/ml. Constant infusion of estradiol in doses to LH-RH infused alone or associated with several similar to the blood production rate in normal infused at a rate of 600 pug/h and 60 /cg/h, respectively, did not inhibit the pituitary response to LH-RH.
DISCUSSION
The present study demonstrates that a constant infusion of physiologi~1 doses of estradiof does not inhibit the response of pituitary ~onadotro~ins to synthetic LH-RH in normal and post-menopausal women. Nevertheless, when estradiol is infused at a rate of 132 pg/h, which is about IO-20 times above the 'normal blood production rate in normal menstruating women, the pituitary LH and FSH responsiveness to LH-RH is completely inhibited. This inhibitory effect can be antagonized by a simultaneous infusion of a synthetic progestogen and probably by one or more of the known natural progestational steroids. These observations confirm and extend our original studies carried out during the follicuIar and luteal phase of the menstrual cycle of normal and post-menopau~l women [12] . In this regard, Keye and Jaffe [13] observed in normal menstruating women a direct inhibitory effect of estradiol upon the pituitary gonadotropins and suggested that increasing concentrations of estradiol were not solely responsible for the increased pituitary responsiveness to LH-RH at midcycle. More recently, Yen et uI.f14] reported that a constant infusion for 6 h of pharmacological doses of estradiol exerts a direct negative feedback action on the pitui~ry gonadotrophs of l~~ogonadal h~ergonadotropic subjects. thus confirming in part our previous findings in post-menopausal women.
It is important to differentiate clearly between pharmacologic versus physiologic effects of sex steroids on the responsiveness of pituitary gonadotropins to synthetic LH-RH. In our studies it was evident that only pharmacological levels of estradiol were capable of biocking the LH---RH pituitary responsiveness and that lower doses selected to mimic the estrogen production rate which exist in the late follicuiar phase of the menstruai cycle did not significantly modify the LH-RH pituitary gonadotropin responsiveness.
The results obtained in normal men demonstrate that a constant infusion of estradiol in doses of 132 +ug/h completely inhibited the pituitary gonadotropin responses to LH-RH administration. On the contrary, testosterone only produced a partial inhibitory effect, and Sa-dihydrotestosterone and chlormadinone acetate did not affect the pituitary responsiveness. It has been reported [ 1% 191 that testosterone and estradiol inhibit the pituitary gonadotropin secretion in men, which can be explained by a diminished ~nsitivity of pituitary gonadotrophs to LH-RH, although a direct negative feedback action on the h~~thaIami~ LH-RH release can not be excluded.
Interesting enough were the responses obtained in the Klinefelter's syndrome patient in whom testosterone and estradiol did not inhibit the pituitary LH and FSH responsiveness to LH-RH administration. These findings explain in part previous reports on the refractoriness of the hypothalamic pituitary axis to the inhibitory effects of the natural gonadal hormones [20-231. On the basis of the data presented in this paper, it can be concluded that sex steroids can modulate the hypothalamic-pitui~ry axis and that estradiol alone does not seem to increase the pituitary sensitivity to LH-RH since it is not sotely responsible for the increased pituitary responsiveness present at the mid-h&al phase. In addition. our data suggest the hypothesis that the increased pituitary responsiveness which facilitates the midcycle LH and FSH surge might be conditioned by the synergistic effect of estradiol and a progestin steroid such as progesterone, I~~-hydrox~rogesterone and the 20~ or 208 reduced derivative of progesterone.
